covid-19: gauging the pandemic · 2020-03-05 · march 2020 5 » covid-19 baseline scenario (middle...

38
March 2020 1 March 2020 COVID-19: Gauging the Pandemic

Upload: others

Post on 15-Apr-2020

5 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 1March 2020

COVID-19: Gauging the Pandemic

Page 2: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 2

Gauging the Pandemic1

Page 3: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 3

China (80,152)S. Korea (5,186)Italy (2,502)Iran (2,336)Diamond Princess (706)Japan (293)France (212)Germany (196)Spain (165)Singapore (110)USA (109)Other (903)

A Global Pandemic

Sources: Worldometer, Moody’s Analytics

Coronavirus cases by location as of Mar 3, 2020

Page 4: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 4

Mumps

Avian flu

Chickenpox

Spanish flu

Ebola

Measles

PolioSARS

Seasonal flu

Smallpox

Swine flu

0.0

0.1

1.0

10.0

100.0

0 2 4 6 8 10 12 14 16

Contagious and VirulentX-axis: Contagiousness (R0), Y-axis: Mortality rate (%, log scale)

Sources: CDC, WHO, Various studies, Moody’s Analytics

COVID-19

Highly contagious

Very deadly

Page 5: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 5

» COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes)

– 1 million global infections, new infections peak in March, 1-2% mortality rate, 3-4% hospitalization rate, infections abate by June.

» COVID-19 Downside Scenario (45% probability actual outcome is worse)

– 1-2 million infections, new infections peak in March,2% mortality rate, 4-5% hospitalization rate, infections abate by June.

» COVID-19 Pandemic Scenario (35% probability actual outcome is worse)

– 3-4 million global infections, new infections peak in April,2-3% mortality rate, 5-6% hospitalization rate, infections abate by July.

COVID-19 Scenarios

Page 6: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 6

Direct Global Impact2

Page 7: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 7

Body Blow to the Chinese Economy…

0.00–0.01%0.01–0.04%0.04–0.14%0.14–0.29%

N/A

XI

TI

QI

SI

GNFU

ZH

SD

HI

JLLIIM

GXYU

GZ HU JI

AN

SA

HB

SXGAJA

HE

HA

SH

BETJ

CH

NI

HN

Cumulative lost output, % of Chinese GDP

Lost output as of March 3=1.3 ppt

Source: Moody’s Analytics

Page 8: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 8

20

25

30

35

40

45

50

55

60

08 09 10 11 12 13 14 15 16 17 18 19 20

Official manufacturingOfficial nonmanufacturingCaixin manufacturing

…That Has Been Slow to RecoverChina PMI, 50=neutral

Sources: National Bureau of Statistics, Markit, Moody’s Analytics Data ends Feb 2020

Page 9: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 9

3

4

5

6

7

8

9

10

11

07 08 09 10 11 12 13 14 15 16 17 18 19 20

Global Trade Has Been DisruptedSouth Korea imports from China, $ bil

Sources: Ministry of Trade, Moody’s Analytics

Page 10: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 10

70

75

80

85

90

95

100

105

1/1/2020 1/13/2020 1/25/2020 2/6/2020 2/18/2020 3/1/2020

Copper WTI

Commodity Prices Take It on the ChinCommodity prices, Dec 31, 2019=100

Sources: EIA, LME, Moody’s Analytics

Page 11: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 11

Fragile Collective Psyche3

Page 12: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 12

1.0

1.2

1.4

1.6

1.8

2.0

29

30

31

32

33

34

35

Jan-20 Feb-20 Mar-20

Wilshire 5000, $ tril (L)

10-yr Treasury Yield (R)

Global Investors Are Skittish…

Sources: Wilshire 5000, Federal Reserve, Moody’s Analytics

Page 13: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 13

0

10

20

30

40

50

16 17 18 19 20

Business sentiment diffusion index, net % of responses

Source: Moody’s Analytics

Brexitvote

Trump elected

Trade war

Governmentshutdown

Tax cuts

…and Businesses On Edge

Trade truce

Page 14: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 14

0

20

40

60

80

100

3/8/2015 3/8/2016 3/8/2017 3/8/2018 3/8/2019

Quarantine Virus Pandemic

Consumer Sentiment Is Fragile…Google search term (worldwide), 100=peak interest

Sources: Google Trends, Moody’s Analytics

Zika virus outbreak

Page 15: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 15

111

112

113

114

115

116

1-Jan-20 15-Jan-20 29-Jan-20 12-Feb-20 26-Feb-20

…And Has Begun to SlumpMorning Consult's Index of U.S. Consumer Sentiment

Sources: Morning Consult, Moody’s Analytics

Page 16: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 16

The Policy Response4

Page 17: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 17

Asian Policymakers Aggressively Respond

Fiscal policy Monetary policy Measures prior to Jan 23

China Government tax relief and subsidies LPR cuts, liquidity injectionsVarious targeted measures including RRR cuts, liquidity injections, increased infrastructure spending via local government bond issuance

Japan No No US$120 bil fiscal stimulus announced in Dec

South Korea No Rate cut in Feb Budget approved in Dec, deficit forecast to widen by 9.1% y/y

Indonesia No Rate cut in FebBudget approved in Sep, government spending to rise by 3% y/y in 2020

Hong Kong Record budget deficit for 19-20 and 20-21 announced

SingaporeBudget deficit forecast to widen to 2.1% of GDP in FY2020, its largest in a decade No

Philippines No Rate cut in FebBudget approved in early Jan, for government spending to rise by 12% y/y, with infrastructure the focus

Malaysia No No Rate cut in Jan

Thailand Yes Rate cut in FebCurrent budget approved on Feb 26 after being delayed since Oct, government spending to rise by 7% y/y

Source: Moody's Analytics

Stimulus in Asia Since COVID-19 Outbreak in January

Page 18: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 18

Federal Reserve on High Alert

Sources: Federal Reserve, Moody’s Analytics

Target fed funds rate, change, bps

-100

-75

-50

-25

0

Oct-98 Jan-01 Sept-01 Aug-07 Jan-08 Oct-08 Mar-20

Intra-meeting Next scheduled meeting

Forecast

Page 19: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 19

Small U.S. Fiscal Policy Response (So Far)

Sources: CBO, Moody’s Analytics

Federal discretionary nondefense funding for emergencies, FY, $ bil

0

30

60

90

120

12 13 14 15 16 17 18 19 20

COVID-19

Page 20: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 20

Global Outlook5

Page 21: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 21

Diminished Growth Prospects in 2020…2020 GDP growth forecast, Mar baseline

Source: Moody’s Analytics

Near or above potentialBelow potentialIn recession

Page 22: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 22

…And a Significant Risk of Recession2020 GDP growth forecast, COVID-19 Pandemic scenario

Source: Moody’s Analytics

Near or above potentialBelow potentialIn recession

Page 23: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 23

Global Recession Under Pandemic ScenarioReal GDP growth, % change annual rate

2020Q1 2020Q2 2020Q3 2020Q4 2019 2020

World January base 2.7 2.9 2.7 2.6 2.5 2.6February base 1.4 3.6 3.1 2.6 2.5 2.4March prelim base 1.0 2.2 3.6 2.7 2.4 2.0Pandemic -1.0 -3.5 -0.9 1.4 2.4 -0.1

United States January base 1.5 2.2 1.5 1.2 2.3 1.8February base 1.2 1.8 1.8 1.4 2.3 1.7March prelim base 1.0 0.8 1.8 2.1 2.3 1.5Pandemic -0.8 -2.9 -2.0 -0.2 2.3 -0.2

China January base 7.2 6.6 5.5 5.8 6.1 6.2February base -0.2 11.5 8.2 5.8 6.1 5.4March base -0.8 5.2 11.5 5.8 6.1 4.5Pandemic -1.8 -8.7 0.0 6.4 6.1 0.1

Brazil January base 2.0 2.4 2.5 2.6 1.1 2.2February base 2.0 2.4 2.5 2.6 1.1 2.2March prelim base 1.6 2.0 2.5 2.6 1.1 2.0Pandemic -6.1 -6.8 -1.6 1.6 1.1 -2.2

United Kingdom January base 1.2 1.1 1.1 1.1 1.3 1.0February base 1.1 1.3 1.1 1.1 1.3 1.0March base 0.7 0.9 1.2 1.0 1.4 0.8Pandemic 0.7 -0.8 -0.2 0.3 1.3 0.3

Euro Zone January base 1.4 1.5 1.8 1.4 1.2 1.3February base 1.7 1.6 1.7 1.4 1.2 1.3March prelim base 1.1 1.2 1.3 1.3 1.2 1.0Pandemic -0.5 -1.3 -0.1 0.8 1.2 -0.1

Page 24: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 24

Supplemental Charts6

Page 25: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 25

Death Rate by Age

Sources: Chinese Center for Disease Control and Prevention, Moody’s Analytics

0 2 4 6 8 10 12 14 16

0-910-1920-2930-3940-4950-5960-6970-79

80+

Case fatality ratio

Page 26: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 26

Death Rate by Health Condition

Sources: Chinese Center for Disease Control and Prevention, Moody’s Analytics

0 2 4 6 8 10 12

No pre-existingconditions

Cancer

Hypertension

Respiratory disease

Diabetes

Cardiovasculardisease

Case fatality ratio

Page 27: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 27

Death Rate by Gender

Sources: Chinese Center for Disease Control and Prevention, Moody’s Analytics

0.0 0.5 1.0 1.5 2.0 2.5 3.0

Female

Male

Case fatality ratio

Page 28: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 28

COVID-19 Is a Pernicious Economic Shock

Source: Moody’s Analytics

Price

OutputQ

P

S

D

S1

D1

P1

Q1

Page 29: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 29

Lost Output

0.1–0.2%0.2–0.9%0.9–3.3%3.3–9.0%

N/A

XI

TI

QI

SI

GNFU

ZH

SD

HI

JLLIIM

GXYU

GZ HU JI

AN

SA

HB

SXGAJA

HE

HA

SH

BETJ

CH

NI

HN

Cumulative lost output, % of province GDP

Source: Moody’s Analytics

Page 30: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 30

0 5 10 15 20 25 30

VietnamThailand

PhilippinesSingapore

AustraliaIndonesiaMalaysiaCanada

U.S. Travel and tourism as direct% of GDPChina as share of totaltourist arrivals by country, %

Exposure to Chinese Tourism

Sources: World Travel and Tourism Council, National statistics offices, Moody’s Analytics

Page 31: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 31

0 5 10 15 20 25 30

TaiwanVietnamMalaysia

KoreaThailand

SingaporePhillipines

AustraliaIndonesia

CanadaHong Kong

U.S.India

Asia Exposed Through Supply ChainExports to China, % of GDP, 2018

Sources: IMF, National statistics offices, Moody’s Analytics

Page 32: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 32

-1.0

-0.8

-0.6

-0.4

-0.2

0.0

U.S. EU China Japan

EMEAEM LatAmEM AsiaDevelopedDirect

Significant Global Knock-On EffectsPpt contribution to global GDP growth from 1% deceleration in GDP growth of specified country

Source: Moody’s Analytics

Page 33: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 33

-2

0

2

4

6

8

10

19Q1 19Q3 20Q1 20Q3 21Q1 21Q3

Jan baseFeb basePandemic

China’s Economic Outlook China real GDP growth, % change yr ago

Sources: Government of China, Moody’s Analytics

Page 34: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 34

-2

-1

0

1

2

3

4

5

19Q1 19Q3 20Q1 20Q3 21Q1 21Q3

Jan baseFeb basePandemic

Global Economic OutlookGlobal real GDP growth, % change yr ago

Source: Moody’s Analytics

Page 35: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 35

-1.5-1.0-0.50.00.51.01.52.02.53.03.54.0

19Q1 19Q3 20Q1 20Q3 21Q1 21Q3

Jan baseFeb basePandemic

U.S. Economic OutlookU.S. real GDP growth, % change yr ago

Sources: BEA, Moody’s Analytics

Page 36: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 36

Q&A

Email us at [email protected]

Page 37: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 [email protected]

West Chester, EBA-HQ+1.610.235.5299121 North Walnut Street, Suite 500West Chester PA 19380USA

New York, Corporate-HQ+1.212.553.16537 World Trade Center, 14th Floor250 Greenwich StreetNew York, NY 10007USA

London+44.20.7772.5454One Canada Square Canary Wharf London E14 5FAUnited Kingdom

Toronto+1.416.681.2133200 Wellington Street West, 15th FloorToronto ON M5V 3C7Canada

Prague+420.22.422.2929AFI ButterflyB1 3rd Floor, Pernerova 691/42186 00 Prague 8 - KarlinCzech Republic

Sydney+61.2.9270.8111Level 10, 1 O'Connell StreetSydney, NSW, 2000Australia

Singapore+65.6511.44006 Shenton Way#14-08 OUE Downtown 2Singapore 068809

Shanghai+86.21.6101.0172Unit 2306, Citigroup Tower33 Huayuanshiqiao RoadPudong New Area, 200120China

Contact Us: Economics & Business Analytics Offices

Page 38: COVID-19: Gauging the Pandemic · 2020-03-05 · March 2020 5 » COVID-19 Baseline Scenario (Middle of the distribution of possible outcomes) – 1 million global infections, new

March 2020 38

© 2020 Moody’s Corporation, Moody’s Investors Service, Inc., Moody’s Analytics, Inc. and/or their licensors and affiliates (collectively, “MOODY’S”). All rights reserved.

CREDIT RATINGS ISSUED BY MOODY'S INVESTORS SERVICE, INC. AND ITS RATINGS AFFILIATES (“MIS”) ARE MOODY’S CURRENT OPINIONS OF THE RELATIVE FUTURE CREDIT RISK OF ENTITIES, CREDIT COMMITMENTS, OR DEBT OR DEBT-LIKE SECURITIES, AND MOODY’S PUBLICATIONS MAY INCLUDE MOODY’S CURRENT OPINIONS OF THE RELATIVE FUTURE CREDIT RISK OF ENTITIES, CREDIT COMMITMENTS, OR DEBT OR DEBT-LIKE SECURITIES. MOODY’S DEFINES CREDIT RISK AS THE RISK THAT AN ENTITY MAY NOT MEET ITS CONTRACTUAL, FINANCIAL OBLIGATIONS AS THEY COME DUE AND ANY ESTIMATED FINANCIAL LOSS IN THE EVENT OF DEFAULT. CREDIT RATINGS DO NOT ADDRESS ANY OTHER RISK, INCLUDING BUT NOT LIMITED TO: LIQUIDITY RISK, MARKET VALUE RISK, OR PRICE VOLATILITY. CREDIT RATINGS AND MOODY’S OPINIONS INCLUDED IN MOODY’S PUBLICATIONS ARE NOT STATEMENTS OF CURRENT OR HISTORICAL FACT. MOODY’S PUBLICATIONS MAY ALSO INCLUDE QUANTITATIVE MODEL-BASED ESTIMATES OF CREDIT RISK AND RELATED OPINIONS OR COMMENTARY PUBLISHED BY MOODY’S ANALYTICS, INC. CREDIT RATINGS AND MOODY’S PUBLICATIONS DO NOT CONSTITUTE OR PROVIDE INVESTMENT OR FINANCIAL ADVICE, AND CREDIT RATINGS AND MOODY’S PUBLICATIONS ARE NOT AND DO NOT PROVIDE RECOMMENDATIONS TO PURCHASE, SELL, OR HOLD PARTICULAR SECURITIES. NEITHER CREDIT RATINGS NOR MOODY’S PUBLICATIONS COMMENT ON THE SUITABILITY OF AN INVESTMENT FOR ANY PARTICULAR INVESTOR. MOODY’S ISSUES ITS CREDIT RATINGS AND PUBLISHES MOODY’S PUBLICATIONS WITH THE EXPECTATION AND UNDERSTANDING THAT EACH INVESTOR WILL, WITH DUE CARE, MAKE ITS OWN STUDY AND EVALUATION OF EACH SECURITY THAT IS UNDER CONSIDERATION FOR PURCHASE, HOLDING, OR SALE.

MOODY’S CREDIT RATINGS AND MOODY’S PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS AND IT WOULD BE RECKLESS AND INAPPROPRIATE FOR RETAIL INVESTORS TO USE MOODY’S CREDIT RATINGS OR MOODY’S PUBLICATIONS WHEN MAKING AN INVESTMENT DECISION. IF IN DOUBT YOU SHOULD CONTACT YOUR FINANCIAL OR OTHER PROFESSIONAL ADVISER.

ALL INFORMATION CONTAINED HEREIN IS PROTECTED BY LAW, INCLUDING BUT NOT LIMITED TO, COPYRIGHT LAW, AND NONE OF SUCH INFORMATION MAY BE COPIED OR OTHERWISE REPRODUCED, REPACKAGED, FURTHER TRANSMITTED, TRANSFERRED, DISSEMINATED, REDISTRIBUTED OR RESOLD, OR STORED FOR SUBSEQUENT USE FOR ANY SUCH PURPOSE, IN WHOLE OR IN PART, IN ANY FORM OR MANNER OR BY ANY MEANS WHATSOEVER, BY ANY PERSON WITHOUT MOODY’S PRIOR WRITTEN CONSENT.

All information contained herein is obtained by MOODY’S from sources believed by it to be accurate and reliable. Because of the possibility of human or mechanical error as well as other factors, however, all information contained herein is provided “AS IS” without warranty of any kind. MOODY'S adopts all necessary measures so that the information it uses in assigning a credit rating is of sufficient quality and from sources MOODY'S considers to be reliable including, when appropriate, independent third-party sources. However, MOODY’S is not an auditor and cannot in every instance independently verify or validate information received in the rating process or in preparing the Moody’s publications.

To the extent permitted by law, MOODY’S and its directors, officers, employees, agents, representatives, licensors and suppliers disclaim liability to any person or entity for any indirect, special, consequential, or incidental losses or damages whatsoever arising from or in connection with the information contained herein or the use of or inability to use any such information, even if MOODY’S or any of its directors, officers, employees, agents, representatives, licensors or suppliers is advised in advance of the possibility of such losses or damages, including but not limited to: (a) any loss of present or prospective profits or (b) any loss or damage arising where the relevant financial instrument is not the subject of a particular credit rating assigned by MOODY’S.

To the extent permitted by law, MOODY’S and its directors, officers, employees, agents, representatives, licensors and suppliers disclaim liability for any direct or compensatory losses or damages caused to any person or entity, including but not limited to by any negligence (but excluding fraud, willful misconduct or any other type of liability that, for the avoidance of doubt, by law cannot be excluded) on the part of, or any contingency within or beyond the control of, MOODY’S or any of its directors, officers, employees, agents, representatives, licensors or suppliers, arising from or in connection with the information contained herein or the use of or inability to use any such information.

NO WARRANTY, EXPRESS OR IMPLIED, AS TO THE ACCURACY, TIMELINESS, COMPLETENESS, MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE OF ANY SUCH RATING OR OTHER OPINION OR INFORMATION IS GIVEN OR MADE BY MOODY’S IN ANY FORM OR MANNER WHATSOEVER.

Moody’s Investors Service, Inc., a wholly-owned credit rating agency subsidiary of Moody’s Corporation (“MCO”), hereby discloses that most issuers of debt securities (including corporate and municipal bonds, debentures, notes and commercial paper) and preferred stock rated by Moody’s Investors Service, Inc. have, prior to assignment of any rating, agreed to pay to Moody’s Investors Service, Inc. for appraisal and rating services rendered by it fees ranging from $1,500 to approximately $2,500,000. MCO and MIS also maintain policies and procedures to address the independence of MIS’s ratings and rating processes. Information regarding certain affiliations that may exist between directors of MCO and rated entities, and between entities who hold ratings from MIS and have also publicly reported to the SEC an ownership interest in MCO of more than 5%, is posted annually at www.moodys.com under the heading “Investor Relations — Corporate Governance — Director and Shareholder Affiliation Policy.”

Additional terms for Australia only: Any publication into Australia of this document is pursuant to the Australian Financial Services License of MOODY’S affiliate, Moody’s Investors Service Pty Limited ABN 61 003 399 657AFSL 336969 and/or Moody’s Analytics Australia Pty Ltd ABN 94 105 136 972 AFSL 383569 (as applicable). This document is intended to be provided only to “wholesale clients” within the meaning of section 761G of the Corporations Act 2001. By continuing to access this document from within Australia, you represent to MOODY’S that you are, or are accessing the document as a representative of, a “wholesale client” and that neither you nor the entity you represent will directly or indirectly disseminate this document or its contents to “retail clients” within the meaning of section 761G of the Corporations Act 2001. MOODY’S credit rating is an opinion as to the creditworthiness of a debt obligation of the issuer, not on the equity securities of the issuer or any form of security that is available to retail investors. It would be reckless and inappropriate for retail investors to use MOODY’S credit ratings or publications when making an investment decision. If in doubt you should contact your financial or other professional adviser.

Additional terms for Japan only: Moody's Japan K.K. (“MJKK”) is a wholly-owned credit rating agency subsidiary of Moody's Group Japan G.K., which is wholly-owned by Moody’s Overseas Holdings Inc., a wholly-owned subsidiary of MCO. Moody’s SF Japan K.K. (“MSFJ”) is a wholly-owned credit rating agency subsidiary of MJKK. MSFJ is not a Nationally Recognized Statistical Rating Organization (“NRSRO”). Therefore, credit ratings assigned by MSFJ are Non-NRSRO Credit Ratings. Non-NRSRO Credit Ratings are assigned by an entity that is not a NRSRO and, consequently, the rated obligation will not qualify for certain types of treatment under U.S. laws. MJKK and MSFJ are credit rating agencies registered with the Japan Financial Services Agency and their registration numbers are FSA Commissioner (Ratings) No. 2 and 3 respectively.

MJKK or MSFJ (as applicable) hereby disclose that most issuers of debt securities (including corporate and municipal bonds, debentures, notes and commercial paper) and preferred stock rated by MJKK or MSFJ (as applicable) have, prior to assignment of any rating, agreed to pay to MJKK or MSFJ (as applicable) for appraisal and rating services rendered by it fees ranging from JPY200,000 to approximately JPY350,000,000.

MJKK and MSFJ also maintain policies and procedures to address Japanese regulatory requirements.